[Clinical characteristics and prognostic analysis of carbapenem-resistant Enterobacteriaceae bloodstream infections in patients with hematologic diseases].
Year: 2024
Type: other
Abstract: The prognosis of CRE BSI in patients with hematological diseases is poor. Timely, appropriate therapy and receipt of a ceftazidime-avibactam-containing regimen can improve survival and prognosis.
Source: PubMed
Authors: L N Zhang, Y Q Cui, Q S Lin, C H Xu, J L Sun, Y G Cao, W B Cao, C Liang, X Chen, W H Zhai, Q L Ma, R L Zhang, J L Wei, D L Yang, A M Pang, Y He, E L Jiang, M Z Han, S Z Feng
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4406053971
